Myriad (MYGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Myriad(MYGN) ZACKS·2024-08-07 08:00
For the quarter ended June 2024, Myriad Genetics (MYGN) reported revenue of $211.5 million, up 15.3% over the same period last year. EPS came in at $0.05, compared to -$0.08 in the year-ago quarter.The reported revenue represents a surprise of +2.91% over the Zacks Consensus Estimate of $205.52 million. With the consensus EPS estimate being -$0.01, the EPS surprise was +600.00%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St ...